City
Epaper

China's zero-Covid strategy risks further economic disruption: Report

By ANI | Updated: February 5, 2022 23:10 IST

China's continuation with its zero-tolerance policy against the COVID-19 is leading to greater public backlash as high inflation is feeding economic insecurity and public discontent amid economic disruption.

Open in App

China's continuation with its zero-tolerance policy against the COVID-19 is leading to greater public backlash as high inflation is feeding economic insecurity and public discontent amid economic disruption.

Indeed, the government has grown more authoritarian and state capitalist especially in the run-up to Xi securing a historic third term at this fall's 20th Party Congress.

US-based consultancy firm Eurasia Group said that in both the cases, the coronavirus pandemic and climate change, Beijing will underperform, both at home and on the global stage.

"That's bad news for a year that will be dominated by two crises in desperate need of a coordinated response: the Covid-19 pandemic and climate change. In both cases, the US and China will underperform, both at home and on the global stage," the report said.

Even though authorities are making efforts to fine-tune containment policies, shifting from massive lockdowns to more targeted, small-scale closures in big cities, the country is still unlikely to pivot away from a very low tolerance for virus cases for the rest of 2022.

"Even in the developed world, the economic hangover from the pandemic will endure with disrupted supply chains and persistent inflation. A more deadly variant emerging remains a tail risk, but it would still pose much less danger given the tools available to fight it (much as Omicron would've felt apocalyptic if it had hit the world pre-vaccines, a year earlier)," the US based consultancy firm said.

"China's problems add to the disruption of supply chains, which will present ongoing risks across the world. Shipping constraints, Covid-19 outbreaks, and shortages of staff, raw material, and equipment--all more acute because of China's zero-Covid policy--will make goods less available. High prices for shipping will also hurt small- and medium-sized businesses that don't have the resources to book containers, let alone their own ships," it added.

It also said that "continuing to use aggressive lockdowns to halt transmission will lead to greater public backlash and economic disruption."

Also on the economic side, persistent, high inflation will be an overarching economic and political challenge. Citizens are still enduring lockdowns, shutdowns, sacrifice, and anxiety--while food and gas prices have soared.

The sectors that will face the biggest hit are also the most important for China's economic rebalancing - services, small and medium-sized enterprises and consumption, as opposed to industry, large firms and investment, the report said.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: beijingchina20th party congressEurasia group
Open in App

Related Stories

InternationalEarthquake In China: Several Missing As Multiple Buildings Collapse After 5.2-Magnitude Quake Hits Liuzhou

InternationalChina Factory Blast: At Least 21 Killed, Over 60 Injured in Explosion at Fireworks Plant in Guandu Township

InternationalChina Miracle: Man Survives After Heart Stops Beating for 40 Hours Using This Technology

International'Illegal Military Operations': China Accuses US and Israel of Strait of Hormuz Crisis

NationalDelhi Government Orders Removal of 2.5 Lakh Chinese CCTV Cameras Over Security Concerns

International Realted Stories

InternationalManoj Kumar Sharma takes charge as 33rd Chief Justice of Nepal

InternationalTaiwan’s exclusion from WHA exposes Chinese manipulation of global legal order: Report

InternationalPutin arrives in Beijing for State Visit to China

InternationalWomen, religious and gender minorities face digital intimidation in Pakistan: Report

InternationalZambia to adapt India’s eVIN platform to strengthen medicine supply chain management